Screener/Healthcare/Biotechnology

VRTX

Vertex Pharmaceuticals IncorporatedNASDAQ
$449.67-1.56 (-0.35%)
Nasdaq 100S&P 500Large CapHealthcareHigh ROELow BetaMost Profitable
$362.50
$513.98
$441.20
$452.08
EPS (TTM)$15.32
P/E Ratio29.35
Dividend Yield—
Market Cap$115.32B
Volume728K
Prev Close$451.24
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$3.2B$1.2B$4.6485.4%37.3%
Q3 '25$3.1B$1.1B$4.2086.5%35.2%
Q2 '25$3.0B$1.0B$3.9986.3%34.8%
Q1 '25$2.8B$646.3M$2.4986.9%23.3%
Q4 '24$2.9B$913.0M$3.5385.5%31.4%
Q3 '24$2.8B$1.0B$4.0185.8%37.7%
Q2 '24$2.6B-$3.6B$-13.9285.9%-135.8%
Q1 '24$2.7B$1.1B$4.2187.3%40.9%
Get Your Daily Market Recap